NDC product
Dorzolamide Hydrochloride
NDC 72266-197 · FOSUN PHARMA USA INC
Key facts
| Product NDC | 72266-197 |
|---|---|
| Proprietary name | Dorzolamide Hydrochloride |
| Nonproprietary name | Dorzolamide Hydrochloride |
| Substances | DORZOLAMIDE HYDROCHLORIDE |
| Dosage form | SOLUTION |
| Route | OPHTHALMIC |
| Labeler | FOSUN PHARMA USA INC |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA215660 |
| Pharmacologic classes | Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA] |
| Marketing start | Jan 23, 2023 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: